Our staff has deemed the following public research links as significant and/or new findings by the global research community in the search for a cure for paralysis. You can search the database by category, keyword, name, and/or date. Keep abreast of cure research breakthroughs by signing up for our research newsletter.

Register To Receive Updates

Click the button below to register to receive regular updates from MCPF.



To search articles by keyword or date, enter your search criteria in the box and click the Search button.

All Articles
1 2 3 4 5 6 7 8 9 10 ...
 

Patients with Complete Paralysis Show Additional Recovery of Arm, Hand and Finger Function at 9-months After Treatment with Asterias' AST-OPC1 posted Tuesday, 13 June 2017
FREMONT, Calif., June 13, 2017 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company pioneering the field of regenerative medicine, today announced that new 9-month follow-up data from the AIS-A 10 million cell cohort in the company's ongoing SCiStar Phase 1/2a clinical trial shows three of six (50%) patients..
Category: Clinical Trials


Neuralstem Expands Phase 1 Safety Trial of NSI-566 Neural Stem Cells in Spinal Injury posted Wednesday, 12 April 2017
GERMANTOWN, Md., April 12, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, announced that a new cohort of four patients will be added to its ongoing Phase 1 human clinical trial evaluating the safety and feasibility of using NSI-566 spinal cord-derived neural stem cells to repair...
Category: Clinical Trials


InVivo to Initiate Cervical Spinal Cord Injury Study posted Thursday, 23 March 2017
- Company Receives Investigational Testing Authorization from Health Canada to Conduct Cervical Spinal Cord Injury Study - March 23, 2017 08:00 AM Eastern Daylight Time CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced that Health Canada has approved the company’s Investigational Testing Authorization application to commence a clinical study of the Neuro-Spinal Scaffold™ in patients with acute, complete...
Category: Clinical Trials


New trial may revolutionise treatment of spinal cord injury patients posted Friday, 20 January 2017
Queensland researchers are launching a world-first clinical trial aimed at improving recovery from spinal cord injuries. In the study, led by The University of Queensland and The Princess Alexandra (PA) Hospital, a new anti-inflammatory drug will be given to participants within hours of spinal trauma in an effort to minimise tissue damage...
Category: Clinical Trials


Paralyzed monkeys regain control of their legs after brain implants posted Thursday, 10 November 2016
By Meera Senthilingam, CNN A new form of brain implant could one day help people with paraplegia regain control of their legs, based on a new study proving its potential in paralyzed monkeys. Researchers at the École polytechnique fédérale de Lausanne (EPFL) in Switzerland were able to restore...
Category: Other Research


Zebrafish Could Help Repair Human Spinal Cord Injuries posted Friday, 04 November 2016
A freshwater fish popular in many home aquariums might hold the key to repairing damaged spinal cords in humans. In a study published in the journal Science, Researchers at Duke University say the zebrafish is able to completely heal its spine -- even after it was severed -- because of a protein that helps...
Category: Other Research


UofL wins $5 million to help spinal patients posted Monday, 24 October 2016
Researchers at the University of Louisville and Columbia University have been awarded a $5 million grant to develop a robotic device to help spinal cord injury patients get their balance back...
Category: Clinical Trials


Regeneration of spinal nerve cells boosted posted Wednesday, 12 October 2016
Researchers successfully boosted the regeneration of mature nerve cells in the spinal cords of adult mammals -- an achievement that could one day translate into improved therapies for patients with spinal cord injuries...
Category: Other Research


Clinical trial offers hope to restore limb function in man with complete cervical spinal cord injury posted Wednesday, 14 September 2016
Physicians at Rush University Medical Center became the first in Illinois to inject AST-OPC1 (oligodendrocyte progenitor cells), an experimental treatment, into the damaged cervical spine of a recently paralyzed man as part of a multicenter clinical trial. Dr. Richard G. Fessler, professor of neurological surgery at Rush University ...
Category: Clinical Trials


Stem Cells Improve Blood Vessel Function Following Spinal Cord Injury posted Tuesday, 19 July 2016
By PR Rocket on July 19, 2016 A new study published in STEM CELLS Translational Medicine (SCTM) by Badner et al shows how a minimally invasive stem cell treatment in rats can reduce secondary damage in traumatic spinal cord injury (SCI).
Category: Stem Cells

1 2 3 4 5 6 7 8 9 10 ...
Morton Cure Paralysis Fund - Minnesota
5021 Vernon Ave., Suite 145
Minneapolis, MN 55436
(612) 904-1420
info@mcpf.org
Morton Cure Paralysis Fund - Arizona
4939 W. Ray Rd., Suite 4190
Chandler, AZ 85226
(612) 904-1420
info@mcpf.org